高级检索
当前位置: 首页 > 详情页

Development and Validation of a Screening Questionnaire of COPD from a Large Epidemiological Study in China

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Japan Friendship Hosp, Inst Clin Med Sciences,Inst Resp Med, Chinese Acad Med Sciences,Natl Ctr Resp Med, Beijing, Beijing, Peoples R China [2]Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China [3]China Japan Friendship Hosp, Ctr Resp Med, Beijing, Peoples R China [4]Natl Ctr Resp Med, Beijing, Peoples R China [5]China Japan Friendship Hosp, Ctr Resp Med, Dept Pulm & Crit Care Med, Beijing, Peoples R China [6]Shanxi Bethune Hosp, Dept Pulm & Crit Care Med, Taiyuan, Peoples R China [7]Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Xian, Shaanxi, Peoples R China [8]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pulm & Crit Care Med, Wuhan, Hubei, Peoples R China [9]Guizhou Prov Peoples Hosp, Dept Pulm & Crit Care Med, Guiyang, Guizhou, Peoples R China [10]Fudan Univ, Zhongshan Hosp, Dept Pulm & Crit Care Med, Shanghai, Peoples R China [11]China Med Univ, Hosp 1, Dept Pulm & Crit Care Med, Shenyang, Liaoning, Peoples R China [12]Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China [13]Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp & Crit Care Med, Hangzhou, Zhejiang, Peoples R China [14]Sichuan Univ, West China Hosp, State Key Lab Biotherapy China, Chengdu, Sichuan, Peoples R China [15]Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Sichuan, Peoples R China [16]Capital Med Univ, Beijing Chao Yang Hosp, Dept Pulm & Crit Care Med, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing, Peoples R China [17]Beijing Inst Resp Med, Beijing, Peoples R China [18]Peking Univ Third Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China [19]Beijing Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China [20]Beijing Hosp, Natl Ctr Gerontol, Beijing, Peoples R China [21]Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll, Beijing, Peoples R China [22]Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Ctr Clin Epidemiol & Evidence Based Med, Beijing, Peoples R China [23]China Japan Friendship Hosp, Tobacco Med & Tobacco Cessat Ctr, Ctr Resp Med, Beijing, Peoples R China [24]Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China [25]WHO Collaborating Ctr Tobacco Cessat & Resp Dis P, Beijing, Peoples R China [26]Capital Med Univ, Beijing Chao Yang Hosp, Dept Stomatol, Beijing, Peoples R China [27]Capital Med Univ, Beijing Chao Yang Hosp, Dept Epidemiol, Beijing, Peoples R China [28]Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA
出处:
ISSN:

关键词: COPD screening scoring system validation

摘要:
Objective We aimed to establish an easy-to-use screening questionnaire with risk factors and suspected symptoms of COPD for primary health care settings. Methods Based on a nationwide epidemiological study of pulmonary health among adults in mainland China (China Pulmonary Health, CPH study) between 2012 and 2015, participants >= 40 years who completed the questionnaire and spirometry tests were recruited and randomly divided into development set and validation set by the ratio of 2:1. Parameters including sex, age, BMI, residence, education, smoking status, smoking pack-years, biomass exposure, parental history of respiratory diseases and daily respiratory symptoms were initially selected for the development of scoring system. Receiver operating characteristic (ROC) curve, area under curve (AUC), positive and negative predictive values were calculated in development set and validation set. Results After random split by 2:1 ratio, 22443 individuals were assigned to development set and 11221 to validation set. Ten variables were significantly associated with COPD independently in development set after a stepwise selection by multivariable logistic model and used to develop scoring system. The scoring system yielded good discrimination, as measured by AUC of 0.7737, and in the validation set, the AUC was 0.7711. When applying a cutoff point of >= 16, the sensitivity in development set was 0.69 (0.67 - 0.71); specificity 0.72 (0.71 - 0.73), PPV 0.25 (0.24 - 0.26) and NPV 0.94 (0.94 - 0.95). Conclusion We developed and validated a comprehensive screening questionnaire, COPD-CPHS, with good discrimination. The score system still needs to be validated by large cohort in the future. Supplemental data for this article is available online at https://doi.org/10.1080/15412555.2022.2042504 .

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 呼吸系统
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 呼吸系统
JCR分区:
出版当年[2020]版:
Q4 RESPIRATORY SYSTEM
最新[2023]版:
Q3 RESPIRATORY SYSTEM

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Japan Friendship Hosp, Inst Clin Med Sciences,Inst Resp Med, Chinese Acad Med Sciences,Natl Ctr Resp Med, Beijing, Beijing, Peoples R China [2]Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China
通讯作者:
通讯机构: [5]China Japan Friendship Hosp, Ctr Resp Med, Dept Pulm & Crit Care Med, Beijing, Peoples R China [*1]2 East Yinghua Rd, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)